Detalhe da pesquisa
1.
Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Physiol Rev
; 101(1): 319-352, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584192
2.
The power of heteronemin in cancers.
J Biomed Sci
; 29(1): 41, 2022 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705962
3.
Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.
Mar Drugs
; 20(8)2022 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005485
4.
Possible Contributions of Nongenomic Actions of Thyroid Hormones to the Vasculopathic Complex of COVID-19 Infection.
Endocr Res
; 47(1): 39-44, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775877
5.
Role of thyroid hormone-integrin αvß3-signal and therapeutic strategies in colorectal cancers.
J Biomed Sci
; 28(1): 24, 2021 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827580
6.
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
Mar Drugs
; 18(7)2020 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32630719
7.
Coronaviruses and Integrin αvß3: Does Thyroid Hormone Modify the Relationship?
Endocr Res
; 45(3): 210-215, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628899
8.
Integrin αvß3 in the Mediating Effects of Dihydrotestosterone and Resveratrol on Breast Cancer Cell Proliferation.
Int J Mol Sci
; 21(8)2020 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32326308
9.
Action of Reverse T3 on Cancer Cells.
Endocr Res
; 44(4): 148-152, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943372
10.
Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer.
Mol Carcinog
; 57(1): 97-105, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28891089
11.
Activation of tumor cell integrin αvß3 by radiation and reversal of activation by chemically modified tetraiodothyroacetic acid (tetrac).
Endocr Res
; 43(4): 215-219, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611723
12.
Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells.
J Biomed Sci
; 24(1): 51, 2017 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750624
13.
Robert I. Gregerman, MD (1930-2021). An Editorial Reminiscence.
Endocr Res
; 47(3-4): 95-103, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36101979
14.
Synthesis of MR-49, a deiodinated analog of tetraiodothyroacetic acid (tetrac), as a novel pro-angiogenesis modulator.
Bioorg Med Chem Lett
; 26(16): 4112-6, 2016 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27381084
15.
Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: an observational study.
Oncologist
; 20(1): 72-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25410096
16.
[THE INVOLVEMENT OF THYROID HORMONES IN CANCER].
Harefuah
; 154(8): 512-5, 540, 2015 Aug.
Artigo
em Hebraico
| MEDLINE | ID: mdl-26480617
17.
Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvß3.
Am J Physiol Cell Physiol
; 307(2): C150-61, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24808494
18.
Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Annu Rev Pharmacol Toxicol
; 51: 99-115, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20868274
19.
Modulation of angiogenesis by thyroid hormone and hormone analogues: implications for cancer management.
Angiogenesis
; 17(3): 463-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24458693
20.
Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.
FASEB J
; 27(8): 3209-16, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23640055